In animal models, GLP-1 reduced infarct size after coronary artery ischemia [75], improved left ventricular ejection volume in heart failure [73], improved glucose uptake in the myocardium [74], and induced nitric oxide-independent vasorelaxation in the endothelium [74]. The gene discussed is GLP1R; the disease is heart failure.